AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...
As a professional product researcher, I’ve seen my fair share of sleep accessories. But Purple’s pillows? These aren’t your run-of-the-mill head cushions. We’re talking proprietary grids ...
Frequent colorectal polyp diagnoses in first- and second-degree relatives are associated with an increased risk for colorectal cancer (CRC), especially early-onset CRC. Researchers evaluated the ...